On Friday, Abbvie Inc (NYSE: ABBV) was 0.10% up from the session before settling in for the closing price of $173.19. A 52-week range for ABBV has been $151.29 – $207.32.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 11.76% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -1.53%. With a float of $1.77 billion, this company’s outstanding shares have now reached $1.77 billion.
In an organization with 50000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 76.85%, operating margin of 24.89%, and the pretax margin is 12.96%.
Abbvie Inc (ABBV) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Abbvie Inc stocks. The insider ownership of Abbvie Inc is 0.08%, while institutional ownership is 72.95%. The most recent insider transaction that took place on Aug 08 ’24, was worth 9,297,210. Before that another transaction happened on Aug 05 ’24, when Company’s EXECUTIVE CHAIRMAN OF BOARD sold 66,500 for $186.52, making the entire transaction worth $12,403,580. This insider now owns 446,599 shares in total.
Abbvie Inc (ABBV) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -1.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.40% during the next five years compared to -5.77% drop over the previous five years of trading.
Abbvie Inc (NYSE: ABBV) Trading Performance Indicators
You can see what Abbvie Inc (ABBV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.52. Likewise, its price to free cash flow for the trailing twelve months is 19.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.87, a number that is poised to hit 2.98 in the next quarter and is forecasted to reach 12.19 in one year’s time.
Technical Analysis of Abbvie Inc (ABBV)
Let’s dig in a bit further. During the last 5-days, its volume was 5.69 million. That was better than the volume of 5.53 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 10.26%. Additionally, its Average True Range was 3.76.
During the past 100 days, Abbvie Inc’s (ABBV) raw stochastic average was set at 21.97%, which indicates a significant increase from 11.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.81% in the past 14 days, which was lower than the 29.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $184.82, while its 200-day Moving Average is $178.98. However, in the short run, Abbvie Inc’s stock first resistance to watch stands at $174.73. Second resistance stands at $176.09. The third major resistance level sits at $177.26. If the price goes on to break the first support level at $172.20, it is likely to go to the next support level at $171.03. The third support level lies at $169.67 if the price breaches the second support level.
Abbvie Inc (NYSE: ABBV) Key Stats
There are 1,767,140K outstanding shares of the company, which has a market capitalization of 306.69 billion. As of now, sales total 54,318 M while income totals 4,863 M. Its latest quarter income was 14,460 M while its last quarter net income were 1,561 M.
